Cargando…
Initial 3-month dynamics of dehydroepiandrosterone sulfate can predict responsiveness to primary androgen deprivation therapy in patients with metastatic prostate cancer
Autores principales: | Yano, Akihiro, Kagawa, Makoto, Takeshita, Hideki, Okada, Yohei, Morozumi, Makoto, Kawakami, Satoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859667/ https://www.ncbi.nlm.nih.gov/pubmed/30924454 http://dx.doi.org/10.4103/aja.aja_9_19 |
Ejemplares similares
-
Rare case of a patient with testicular torsion complicated by acute pneumonia, requiring emergency surgery, during the COVID‐19 pandemic
por: Arai, Masahiro, et al.
Publicado: (2021) -
Foreign-body granuloma mimicking post-chemotherapy residual seminoma: A case of true-negative findings using diffusion-weighted whole-body magnetic resonance imaging with background suppression
por: Takeshita, Hideki, et al.
Publicado: (2018) -
Dehydroepiandrosterone Sulfate, an Adrenal Androgen, Is Inversely Associated with Prevalence of Dynapenia in Male Individuals with Type 2 Diabetes
por: Yasui, Saya, et al.
Publicado: (2023) -
Hyposecretion of the adrenal androgen dehydroepiandrosterone sulfate and its relation to clinical variables in inflammatory arthritis
por: Dessein, Patrick H, et al.
Publicado: (2001) -
Phase II Study of Dehydroepiandrosterone in Androgen Receptor‐Positive Metastatic Breast Cancer
por: Pietri, Elisabetta, et al.
Publicado: (2018)